Novavax, Inc. (NVAX)

7.995 -0.20 (-2.38%) USD  |  NASDAQ  |  Jan 15, 10:13
More

Novavax CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for NVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Moderna, Inc. Upgrade
Merck & Co., Inc. Upgrade
Arcturus Therapeutics Holdings, Inc. Upgrade
Denali Therapeutics, Inc. --